In this respect, acute exposures to IFNs suppress survival of cancer cells, whereas chronic low levels of IFN production induce U-ISGF3-mediated ISGs and the IRDS to provide protection against replicative stress [16]. The gene discussed is IRF9; the disease is cancer.